GLP-1 Agonists Address Metabolic Risk in Psoriatic Disease - Dermatology Times

GLP-1 Agonists Address Metabolic Risk in Psoriatic Disease  Dermatology TimesAnti-Inflammatory Effects of GLP-1 Medications in Psoriasis and Obesity  Dermatology Times